Can You Take Sildenafil and Tadalafil Together? Evidence, Risks, and Compounded Blends
The internet often treats a compounded tablet as proof that two drugs are safe together. That is backwards. The existence of a marketed blend does not replace controlled evidence or an individual interaction review.
Bottom line: Do not combine sildenafil and tadalafil on your own. The approved Viagra and Cialis labels state that combinations with other PDE5 inhibitors or ED therapies have not been adequately studied, may further lower blood pressure, and are not recommended. A compounded blend does not receive FDA approval as a finished combination.
In this guide
- Two brand names, one drug class
- Why compounded dual-PDE5 products are sold anyway
- The risks are not limited to blood pressure
- What a prescriber would need to know before even considering it
- How to read a compounded combination label
- Commercial options deserve the same skepticism
- Why single-agent failure should be investigated first
- Frequently asked questions
Two brand names, one drug class
Sildenafil and tadalafil both inhibit PDE5 and support the nitric-oxide/cGMP pathway involved in penile blood flow. Their timing differs, but their mechanisms overlap. Using both can increase total PDE5-inhibitor exposure rather than creating two independent pathways that neatly add benefit without adding risk.
The Viagra label states that safety and efficacy of combinations with other PDE5 inhibitors or other ED therapies have not been studied and that such combinations may further lower blood pressure. The Cialis label similarly tells patients not to take tadalafil with other PDE5 inhibitors. These are stronger statements than “ask your pharmacist if convenient.”
Why compounded dual-PDE5 products are sold anyway
Compounding allows a licensed compounder to prepare a patient-specific medication when a clinician determines that the patient has a need not met by an available approved product. Telehealth companies also market standardized-looking troches, chews, and tablets containing more than one active ingredient.
The fact that a clinician can prescribe a compounded combination does not mean FDA reviewed the finished product for safety, effectiveness, quality, dose balance, or superiority. FDA explicitly distinguishes compounded drugs from approved generics. The combination may be selected in individual practice, but the evidence and oversight are not the same as for an FDA-approved fixed-dose product.
Some marketing implies that the longer tadalafil window plus a sildenafil “boost” solves timing. That is a commercial theory, not a universal clinical conclusion.
The risks are not limited to blood pressure
| Potential problem | Why overlap matters |
|---|---|
| Hypotension | Both drugs vasodilate. Risk can rise further with alpha-blockers, antihypertensives, dehydration, alcohol, or interacting drugs. |
| Headache, flushing, dizziness | Class effects may become more intense as exposure increases. |
| Priapism or prolonged erection | Both labels carry the four-hour emergency warning, and combining ED therapies may increase concern. |
| Vision or hearing symptoms | Both drugs carry class warnings; a combination does not dilute them. |
| Dosing confusion | Patients may forget that daily tadalafil is already present or may add a separate tablet on top of a combination product. |
| Attribution | When a reaction occurs, it is harder to identify which ingredient, dose, or interaction caused it. |
What a prescriber would need to know before even considering it
A responsible evaluation should establish prior response to each drug alone, dose and timing, reasons for inadequate response, correct use, food and alcohol factors, stimulation, testosterone or vascular issues, and whether the diagnosis needs further work. “One pill did not work once” is not a strong foundation for dual therapy.
The clinician also needs nitrates, alpha-blockers, antihypertensives, CYP3A4 inhibitors, kidney and liver function, cardiovascular status, prior priapism, sensory events, and every other ED product. A patient using a daily tadalafil prescription must disclose it even if the new product is purchased from a different platform.
Sometimes the better next step is correcting timing, changing the single-agent regimen, treating anxiety, addressing cardiovascular risk, using a vacuum device, or evaluating injection therapy rather than adding a second PDE5 inhibitor.
How to read a compounded combination label
- List every active ingredient and strength per unit.
- Confirm whether the displayed dose is per tablet, per troche, or per serving.
- Identify the dispensing pharmacy and state license.
- Check beyond-use date, storage, and whether the product can be divided.
- Look for explicit nitrate, alpha-blocker, priapism, vision, and hearing warnings.
- Ask whether separate sildenafil or tadalafil must be stopped and for how long.
- Confirm renewal, dose changes, and the route for reporting adverse effects.
A proprietary formula name is not sufficient. If the company will not disclose active strengths before payment, the patient cannot meaningfully compare exposure or risk.
Commercial options deserve the same skepticism
MadeMed
A telehealth option currently promoting a compounded troche that combines tadalafil, PT-141, and oxytocin. Verify the live formula, pharmacy, price, and renewal terms at checkout.
Review MadeMedPaid provider link
Availability, pricing, formula, and prescribing decisions can change. Confirm all material terms directly with the provider before purchasing.
BraveRX
A multi-formula compounded ED provider. Check the exact ingredient list, dose, pack size, pharmacy identity, and recurring terms for the selected product.
Review BraveRXPaid provider link
Availability, pricing, formula, and prescribing decisions can change. Confirm all material terms directly with the provider before purchasing.
MangoRx
A provider using performance-focused marketing for sublingual compounded formulas. Treat onset and ingredient claims as provider claims until independently supported.
Review MangoRxPaid provider link
Availability, pricing, formula, and prescribing decisions can change. Confirm all material terms directly with the provider before purchasing.
These links are included for comparison, not as an endorsement of combining sildenafil and tadalafil. Formulas change. Review the live ingredient panel and ask the prescriber why the selected combination is preferable to an FDA-approved single-agent option for the specific patient.
Why single-agent failure should be investigated first
Before escalating to two PDE5 inhibitors, confirm that the first treatment was actually tested under interpretable conditions. Sildenafil taken immediately after a heavy meal, a dose used without adequate stimulation, a first attempt during substantial alcohol use, or tadalafil judged after only one poorly timed event does not establish pharmacologic failure.
Repeated failure can also be a cardiovascular, neurological, hormonal, medication-related, or psychological signal. Severe diabetes, pelvic surgery, low testosterone with reduced desire, antidepressant effects, performance anxiety, and relationship stress may require different interventions. Adding more vasodilator exposure can obscure the underlying diagnosis while increasing adverse effects.
A useful clinician review asks what “did not work” means: no change at all, partial firmness, loss before penetration, short duration, delayed response, or side effects that interrupted the attempt. Those patterns can lead to different next steps. Combination treatment should be a reasoned decision after this analysis, not the automatic next tier in an online product menu.
Frequently asked questions
Can I take sildenafil at night if I took daily tadalafil in the morning?
Do not assume the time gap prevents overlap. Tadalafil has a long exposure window. A prescriber who knows the regimen must determine whether any combination is appropriate.
Is a compounded pill safer than taking two separate tablets?
Not inherently. It may reduce pill count, but the finished compounded combination is not FDA-approved and may make dose adjustment and attribution harder.
Does taking both guarantee a stronger erection?
No. More class exposure does not guarantee better response and may increase adverse effects. Failure may reflect timing, food, anxiety, stimulation, vascular disease, or another cause.
What if my doctor specifically prescribed both?
Follow that clinician’s written regimen and confirm the exact timing, maximum frequency, other products to avoid, and emergency plan. Do not extrapolate the prescription to higher or additional doses.
Continue the series
Sources and review basis
- VIAGRA (sildenafil citrate) prescribing information — DailyMed Accessed July 17, 2026.
- CIALIS (tadalafil) prescribing information — DailyMed Accessed July 17, 2026.
- Understanding the Risks of Compounded Drugs — FDA Accessed July 17, 2026.
- Compounding and the FDA: Questions and Answers — FDA Accessed July 17, 2026.
- Management of Erectile Dysfunction — European Association of Urology guideline Accessed July 17, 2026.
This page summarizes general labeling, regulatory, guideline, and research information. It does not replace an individual assessment by a licensed clinician.